C11.1
Malignant neoplasm of posterior wall of nasopharynx
Clinical Classification Guidelines
Inclusion Terms
- Malignant neoplasm of adenoid
- Malignant neoplasm of pharyngeal tonsil
Medical Intelligence & Overview
Malignant neoplasm of the posterior wall of the nasopharynx, classified under ICD-10 code C11.1, refers to a type of cancer that originates in the tissues of the back part of the nasopharynx. The nasopharynx is the upper part of the throat located behind the nose. This condition is part of a group of cancers linked to the nasopharyngeal region, often involving the adenoid and pharyngeal tonsil areas. Early identification and understanding of this cancer are essential for effective management and treatment.
Causes & Symptoms
Clinical Causes: Epstein-Barr virus (EBV) infection Genetic predisposition Environmental exposures such as certain chemicals or occupational hazards Dietary factors, including the consumption of preserved foods Smoking and heavy alcohol use Family history of head and neck cancers
Key Symptoms: Nasal congestion or blockage Unilateral ear pain or hearing loss Nasal voice or speech difficulty Persistent sore throat or throat pain Neck lumps due to lymph node involvement Blood-tinged nasal discharge Facial numbness or swelling Unexplained weight loss Fever and fatigue in advanced stages
Diagnostic & Treatment
Diagnosis Path: - Blood tests to check overall health and assess EBV involvement
Treatment Protocols: - Targeted therapies and immunotherapy are emerging avenues for certain cases
Clinical Advice & FAQs
Billing Guidance
Is C11.1 a billable ICD-10 code?
Yes, C11.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C11.1?
Clinical documentation must specify the nature of Malignant neoplasm of posterior wall of nasopharynx and any associated comorbidities for accurate reporting.
Cite this Clinical Reference